Clinical Program Principal, Emerging Therapeutics
Evernorth
Woodbury, MN
Aimee Tharaldson is a Clinical Program Principal in the Emerging Therapeutics department at Evernorth. She is responsible for monitoring and analyzing the specialty pharmaceutical pipeline. The Emerging Therapeutics department produces several proprietary reports on the pipeline for use by Evernorth's employees and clients. In her role, Aimee contributes to timely communications on a variety of clinical topics including new drug approvals and other high-impact emerging issues. She also played a key role in developing, and currently helps manage, Evernorth's specialty drug list.
Dr. Tharaldson has spent twenty years in the pharmacy-benefit-management industry. She received her Doctor of Pharmacy degree from the University of Minnesota, College of Pharmacy. She also completed a Pharmacy Practice residency at the Minneapolis VA Medical Center.
Disclosure information not submitted.
(K1) Specialty Pharmaceuticals in Development
Wednesday, October 18, 2023
8:00 AM – 9:15 AM East Coast USA Time